Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lebrun

Showing results (171-180 of 202) with videos related to

Pageof 21
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 19, 2008
Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profileC Lebrun, C Bensa, M Debouverie, et al.
Journal of the Neurological Sciences|February 5, 2004
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patientsH Zephir, J de Seze, A Duhamel, et al.
Neurology|March 24, 2004
Acute aphasia in multiple sclerosis: A multicenter study of 22 patientsA Lacour, J De Seze, E Revenco, et al.
The Journal of Pediatrics|September 20, 2001
Interferon-beta treatment in patients with childhood-onset multiple sclerosisY Mikaeloff, T Moreau, M Debouverie, et al.
Journal of the Neurological Sciences|January 30, 2017
Monitoring CD27+ memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric studyM Cohen, G Romero, J Bas, et al.
Revue Neurologique|September 20, 2023
Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRIC Landes-Chateau, M Levraut, M Cohen, et al.
Neurology|May 26, 2004
Long-term outcome of oligodendrogliomasC Lebrun, D Fontaine, A Ramaioli, et al.
Pathologie-Biologie|November 9, 2004
[Risk factors for Abacavir-induced hypersensibility syndrome in the "real world"]C Chirouze, L Hustache-Mathieu, C Rougeot, et al.
Allergy|November 25, 2017
Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1S Brier, M Le Mignon, K Jain, et al.
Revue Neurologique|October 2, 2021
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trialM Michel, E Le Page, D A Laplaud, et al.
Pageof 21

Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
Journal of Neurology, Neurosurgery, and Psychiatry|January 19, 2008
Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profileC Lebrun, C Bensa, M Debouverie, et al.
Journal of the Neurological Sciences|February 5, 2004
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patientsH Zephir, J de Seze, A Duhamel, et al.
Neurology|March 24, 2004
Acute aphasia in multiple sclerosis: A multicenter study of 22 patientsA Lacour, J De Seze, E Revenco, et al.
The Journal of Pediatrics|September 20, 2001
Interferon-beta treatment in patients with childhood-onset multiple sclerosisY Mikaeloff, T Moreau, M Debouverie, et al.
Journal of the Neurological Sciences|January 30, 2017
Monitoring CD27+ memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric studyM Cohen, G Romero, J Bas, et al.
Revue Neurologique|September 20, 2023
Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRIC Landes-Chateau, M Levraut, M Cohen, et al.
Neurology|May 26, 2004
Long-term outcome of oligodendrogliomasC Lebrun, D Fontaine, A Ramaioli, et al.
Pathologie-Biologie|November 9, 2004
[Risk factors for Abacavir-induced hypersensibility syndrome in the "real world"]C Chirouze, L Hustache-Mathieu, C Rougeot, et al.
Allergy|November 25, 2017
Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1S Brier, M Le Mignon, K Jain, et al.
Revue Neurologique|October 2, 2021
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trialM Michel, E Le Page, D A Laplaud, et al.
Pageof 21